Professional Summary »
Specializing In »
Practice Locations »
Patient Ratings »
Referring Physicians »
Professional Summary
Professional Education
- Board Certification: American Board of Thoracic Surgery, Thoracic and Cardiovascular Surgery (2019)
- Fellowship: Stanford University Thoracic Surgery Fellowship (2018) CA
- Board Certification, Cardiothoracic Surgery, American Board of Thoracic Surgery (2019)
- Fellowship: Stanford University Dept of Cardiothoracic Surgery (2018) CA
- Board Certification: American Board of Surgery, General Surgery (2016)
- Residency: Hospital of University of Pennsylvania Surgery Residency (2016) PA
- Medical Education: Columbia University College of Physicians and Surgeons (2008) NY
Publications
-
Preclinical evaluation of the engineered stem cell chemokine stromal cell-derived factor 1a analog in a translational ovine myocardial infarction model.
Macarthur, J. W., Cohen, J. E., McGarvey, J. R., Shudo, Y., Patel, J. B., Trubelja, A., … Woo, Y. J. (2014). Preclinical evaluation of the engineered stem cell chemokine stromal cell-derived factor 1a analog in a translational ovine myocardial infarction model. Circulation Research, 114(4), 650–59. -
Bioengineered Stromal Cell- Derived Factor-1 alpha Analogue Delivered as an Angiogenic Therapy Significantly Restores Viscoelastic Material Properties of Infarcted Cardiac Muscle
Trubelja, A., MacArthur, J. W., Sarver, J. J., Cohen, J. E., Hung, G., Shudo, Y., … Woo, Y. J. (2014). Bioengineered Stromal Cell- Derived Factor-1 alpha Analogue Delivered as an Angiogenic Therapy Significantly Restores Viscoelastic Material Properties of Infarcted Cardiac Muscle. JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME, 136(8). -
A bioengineered hydrogel system enables targeted and sustained intramyocardial delivery of neuregulin, activating the cardiomyocyte cell cycle and enhancing ventricular function in a murine model of ischemic cardiomyopathy.
Cohen, J. E., Purcell, B. P., Macarthur, J. W., Mu, A., Shudo, Y., Patel, J. B., … Woo, Y. J. (2014). A bioengineered hydrogel system enables targeted and sustained intramyocardial delivery of neuregulin, activating the cardiomyocyte cell cycle and enhancing ventricular function in a murine model of ischemic cardiomyopathy. Circulation. Heart Failure, 7(4), 619–26. -
Tissue-engineered, hydrogel-based endothelial progenitor cell therapy robustly revascularizes ischemic myocardium and preserves ventricular function.
Atluri, P., Miller, J. S., Emery, R. J., Hung, G., Trubelja, A., Cohen, J. E., … Woo, Y. J. (2014). Tissue-engineered, hydrogel-based endothelial progenitor cell therapy robustly revascularizes ischemic myocardium and preserves ventricular function. Journal of Thoracic and Cardiovascular Surgery, 148(3), 1090–98. -
Combined heart and liver transplantation can be safely performed with excellent short- and long-term results.
Atluri, P., Gaffey, A., Howard, J., Phillips, E., Goldstone, A. B., Hornsby, N., … Woo, Y. J. (2014). Combined heart and liver transplantation can be safely performed with excellent short- and long-term results. Annals of Thoracic Surgery, 98(3), 858–62. -
Natural history of coexistent tricuspid regurgitation in patients with degenerative mitral valve disease: Implications for future guidelines
Goldstone, A. B., Howard, J. L., Cohen, J. E., MacArthur, J. W., Atluri, P., Kirkpatrick, J. N., & Woo, Y. J. (2014). Natural history of coexistent tricuspid regurgitation in patients with degenerative mitral valve disease: Implications for future guidelines. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 148(6), 2802–9. -
Shear-Thinning Supramolecular Hydrogels with Secondary Autonomous Covalent Crosslinking to Modulate Viscoelastic Properties In Vivo
Rodell, C. B., MacArthur, J. W., Dorsey, S. M., Wade, R. J., Wang, L. L., Woo, Y. J., & Burdick, J. A. (2015). Shear-Thinning Supramolecular Hydrogels with Secondary Autonomous Covalent Crosslinking to Modulate Viscoelastic Properties In Vivo. ADVANCED FUNCTIONAL MATERIALS, 25(4), 636–44. -
A "Repair-All" Strategy for Degenerative Mitral Valve Disease Safely Minimizes Unnecessary Replacement.
Goldstone, A. B., Cohen, J. E., Howard, J. L., Edwards, B. B., Acker, A. L., Hiesinger, W., … Woo, Y. J. (2015). A "Repair-All" Strategy for Degenerative Mitral Valve Disease Safely Minimizes Unnecessary Replacement. Annals of Thoracic Surgery, 99(6), 1983–90. -
Evaluation of late aortic insufficiency with continuous flow left ventricular assist device†.
Hiraoka, A., Cohen, J. E., Shudo, Y., Macarthur, J. W., Howard, J. L., Fairman, A. S., … Woo, Y. J. (2015). Evaluation of late aortic insufficiency with continuous flow left ventricular assist device†. European Journal of Cardio-Thoracic Surgery , 48(3), 400–406. -
A Tissue-Engineered Chondrocyte Cell Sheet Induces Extracellular Matrix Modification to Enhance Ventricular Biomechanics and Attenuate Myocardial Stiffness in Ischemic Cardiomyopathy
Shudo, Y., Cohen, J. E., MacArthur, J. W., Goldstone, A. B., Otsuru, S., Trubelja, A., … Woo, Y. J. (2015). A Tissue-Engineered Chondrocyte Cell Sheet Induces Extracellular Matrix Modification to Enhance Ventricular Biomechanics and Attenuate Myocardial Stiffness in Ischemic Cardiomyopathy. TISSUE ENGINEERING PART A, 21(19-20), 2515–25. -
A "Repair-All" Strategy for Degenerative Mitral Valve Disease Safely Minimizes Unnecessary Replacement
Goldstone, A. B., Cohen, J. E., Howard, J. L., Edwards, B. B., Acker, A. L., Hiesinger, W., … Woo, Y. J. (2015). A "Repair-All" Strategy for Degenerative Mitral Valve Disease Safely Minimizes Unnecessary Replacement. ANNALS OF THORACIC SURGERY, 99(6), 1983–91. -
Isolation and trans-differentiation of mesenchymal stromal cells into smooth muscle cells: Utility and applicability for cell-sheet engineering.
Shudo, Y., Cohen, J. E., Goldstone, A. B., MacArthur, J. W., Patel, J., Edwards, B. B., … Woo, Y. J. (2016). Isolation and trans-differentiation of mesenchymal stromal cells into smooth muscle cells: Utility and applicability for cell-sheet engineering. Cytotherapy, 18(4), 510–17. -
Biochemically engineered stromal cell-derived factor 1-alpha analog increases perfusion in the ischemic hind limb.
Edwards, B. B., Fairman, A. S., Cohen, J. E., Macarthur, J. W., Goldstone, A. B., Woo, J. B., … Woo, Y. J. (2016). Biochemically engineered stromal cell-derived factor 1-alpha analog increases perfusion in the ischemic hind limb. Journal of Vascular Surgery, 64(4), 1093–99. -
Injectable Bioengineered Hydrogel Therapy in the Treatment of Ischemic Cardiomyopathy.
MacArthur, J. W., Steele, A. N., Goldstone, A. B., Cohen, J. E., Hiesinger, W., & Woo, Y. J. (2017). Injectable Bioengineered Hydrogel Therapy in the Treatment of Ischemic Cardiomyopathy. Current Treatment Options in Cardiovascular Medicine, 19(4), 30-? -
An innovative biologic system for photon-powered myocardium in the ischemic heart.
Cohen, J. E., Goldstone, A. B., Paulsen, M. J., Shudo, Y., Steele, A. N., Edwards, B. B., … Woo, Y. J. (2017). An innovative biologic system for photon-powered myocardium in the ischemic heart. Science Advances, 3(6), e1603078. -
Non-resectional leaflet remodeling mitral valve repair preserves leaflet mobility: A quantitative echocardiographic analysis of mitral valve configuration
Shudo, Y., Cohen, J. E., MacArthur, J. W., Goldstone, A. B., Hiraoka, A., Howard, J., … Woo, Y. J. (2015). Non-resectional leaflet remodeling mitral valve repair preserves leaflet mobility: A quantitative echocardiographic analysis of mitral valve configuration. INTERNATIONAL JOURNAL OF CARDIOLOGY, 186, 16–18. -
SDF 1-alpha Attenuates Myocardial Injury Without Altering the Direct Contribution of Circulating Cells.
Goldstone, A. B., Burnett, C. E., Cohen, J. E., Paulsen, M. J., Eskandari, A., Edwards, B. E., … Woo, Y. J. (2018). SDF 1-alpha Attenuates Myocardial Injury Without Altering the Direct Contribution of Circulating Cells. Journal of Cardiovascular Translational Research. -
The tip of the iceberg: Evaluating the mechanism behind dehiscence of mitral annuloplasty rings.
MacArthur, J. W., & Boyd, J. (2017). The tip of the iceberg: Evaluating the mechanism behind dehiscence of mitral annuloplasty rings. The Journal of Thoracic and Cardiovascular Surgery. -
Cell transplantation in heart failure: where do we stand in 2016?
MacArthur, J. W., Goldstone, A. B., Cohen, J. E., Hiesinger, W., & Woo, Y. J. (2016). Cell transplantation in heart failure: where do we stand in 2016? EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 50(3), 396–99. -
Stem Cell Therapy: Healing or Hype? Why Stem Cell Delivery Doesn't Work
Steele, A. N., MacArthur, J. W., & Woo, Y. J. (2017). Stem Cell Therapy: Healing or Hype? Why Stem Cell Delivery Doesn't Work. CIRCULATION RESEARCH, 120(12), 1868–70. -
Shear-Thinning Supramolecular Hydrogels with Secondary Autonomous Covalent Crosslinking to Modulate Viscoelastic Properties In Vivo.
Rodell, C. B., MacArthur, J. W., Dorsey, S. M., Wade, R. J., Wang, L. L., Woo, Y. J., & Burdick, J. A. (2015). Shear-Thinning Supramolecular Hydrogels with Secondary Autonomous Covalent Crosslinking to Modulate Viscoelastic Properties In Vivo. Advanced Functional Materials, 25(4), 636–644. -
Bioengineered analog of stromal cell-derived factor 1a preserves the biaxial mechanical properties of native myocardium after infarction.
Wang, H., Wisneski, A., Paulsen, M. J., Imbrie-Moore, A., Wang, Z., Xuan, Y., … Woo, Y. J. (2019). Bioengineered analog of stromal cell-derived factor 1a preserves the biaxial mechanical properties of native myocardium after infarction. Journal of the Mechanical Behavior of Biomedical Materials, 96, 165–71.
Practice Locations
Aortic Disease Center Stanford, CA
Stanford, CA
Aortic Disease Center
300 Pasteur Drive, 3rd Floor, Clinic A31
Stanford , CA 94305
Make An Appointment More Clinic Information » Getting Here »Valvular Heart Disease Clinic Stanford, CA
Stanford, CA
Valvular Heart Disease Clinic
300 Pasteur Drive, 3rd Floor, Clinic A31
Stanford , CA 94305
Make An Appointment More Clinic Information » Getting Here »Structural Heart Program Stanford, CA
Stanford, CA
Structural Heart Program
300 Pasteur Drive
Stanford , CA 94305
Make An Appointment More Clinic Information » Getting Here »Heart Transplant Program Stanford, CA
Stanford, CA
Heart Transplant Program
300 Pasteur Drive , 2nd Floor, Room A21
Stanford , CA 94305
Make An Appointment More Clinic Information » Getting Here »Lung Transplant Program Stanford, CA
Stanford, CA
Lung Transplant Program
300 Pasteur Drive
Stanford , CA 94305
Make An Appointment More Clinic Information » Getting Here »Patient Reviews
(22 reviews)
everyone that I talked to was very friendly, and explained to me what to expect.
Dr. John Macarthur made me feel very confident about the up coming procedure.
Thorough.
Thank you
He was very easy to talk to and prepared to answer any question we had, and appeared very knowledgeable in the heart medical field. I was very grateful that he was of the opinion that he could repair or replace my calcified, worn out and poor functioning Mitral Valve that can hopefully grant me a few more years of life on this beautiful earth.. Also in the process of doing so, possibly give him additional knowledge that could help someone in the future, including my two Sons who were born into a family with a background of heart problems.
He is a very good doctor. It wasn't his fault for the video appointment screw up
Alway great at Stanford
Very thorough and explained my situation in a manner that was understandable.
very thorough and informative
He was very engaging and helpful.
I enjoy my visit the staff was great very helpful and took good care of me
Dr. MacArthur and his team are fabulous. Excellent care. Dr. MacArthur is compassionate, answered all my questions and put a lot of my concerns and worries at ease. I really like that Dr. MacArthur listened to me and did not rush through my visit. â ¤ï¸ â€ ðŸ©¹
Very friendly and down to earth which made it easier to feel comfortable talking about all my medical concerns. Explained things in a way a non medical person can understand. I appreciate his positive demeanor. I feel privileged that I was accepted by Dr. MacArthur and Dr. Woo for my complicated surgery.
Exceptionally professional . He answered all my questions. I appreciated the time that I spent with him.
Very informative and personable. Instilled confidence in me about the procedure and the outcomes.
He is the best
Most excellent.
He made me feel confident that I was in good hands. He seemed knowledgeable and I feel I can trust his opinion.
He took the time out between surgeries to speak with me, answered all my questions, and didn't make me feel like he was in a hurry.
He was very thorough and understanding and patiently answered all of my questions which were a lot. I really appreciate that.
All staff members top quality, knowledgable, efficient, and friendly. Makes everything much less stressful for the patient for sure.
Very informative and answered questions easily and accurately.
View More »
Referring Physicians
PHYSICIAN HELPLINE
Phone: 1-866-742-4811
Fax: 650-320-9443
Monday – Friday, 8 a.m. – 5 p.m.
Fax: 650-320-9443
Monday – Friday, 8 a.m. – 5 p.m.
Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referring Physicians.
You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or e-mail the Referral Center at ReferralCenter@stanfordhealthcare.org
- Send referrals online
- View referral status
- Access medical records